Supreme Court Correct to Uphold Right of Injured Patients To Sue Drug Companies
Statement of Brian Wolfman, Director, Litigation Group at Public Citizen
March 4, 2009 -- "We are extremely gratified that the U.S. Supreme Court today in Wyeth v. Levine upheld the traditional right of patients harmed by defective and mislabeled drugs to sue drug companies to recover compensation for their injuries.
Drug companies are not perfect, and they sometimes fail to identify and inform doctors and the Food and Drug Administration (FDA) of problems with their products or their products’ labels. Nor is the FDA perfect. It is overworked and underfunded, and it depends almost entirely on drug companies for information about the safety and effectiveness of drugs.
Perhaps most important, once a drug is marketed to thousands of people, we learn of things that we never knew in the clinical trials for that drug – problems that arise over the years as doctors prescribe and patients take the drug day in and day out.
For all these reasons, legal immunity for drug manufacturers – as called for by the drug companies and the Bush administration – would have been a huge mistake. We believe that the Supreme Court appreciated that. The Supreme Court also appreciated that the civil justice system is consistent with, and indeed helps support, FDA authority to make drugs as safe and as effective as possible. The court emphatically rejected the drug company and Bush administration argument that compensation for patients was an obstacle to the accomplishment of the FDA’s safety objectives.
Finally, and most important, there are real people involved here. The plaintiff in the case, Diana Levine, lost her arm because Wyeth did not take a simple step to warn her doctors of an avoidable risk of gangrene that was well known to the company – that its anti-nausea drug should not have been administered via the IV-push method. Today’s decision is a huge victory for Diana, for patients across the country and for public health."
For more information, visit http://www.citizen.org/documents/levinecertopp.pdf andhttp://www.citizen.org/documents/preemptiontrialarticle.pdf.
Source: Public Citizen
Related articles
- 2009-03-05: Supreme Court Correct to Uphold Right of Injured Patients To Sue Drug Companies
- 2008-05-22: Illinois AG Madigan, 29 States Reach $58 Million Settlement With Merck
- 2008-05-22: Idaho to Receive More than $1.1 Million from Vioxx Maker Merck
- 2008-05-22: Florida AG Files $58 Million Multistate Judgment to Resolve Three-Year Investigation into Merck Pharmaceutical
- 2008-05-22: $58 Million Merck Settlement To Change Deceptive TV Drug Advertisements
- 2009-10-20: FDA approves GlaxoSmithKline’s Votrient for advanced renal cell cancer
- 2009-10-19: Rep. Israel Calls on Congress to Pass Counterfeit Drugs Legislation Amid Concerns About Fake H1N1 Medications
- 2009-10-08: Novartis completes shipment of US supply of Fluvirin® seasonal influenza vaccine
- 2009-10-01: Senator Cantwell Protects Consumers From Paying Artificially High Rx Drug Prices Due To Industry Manipulation
- 2009-06-22: Merck Responds to FDA on Leukotriene Inhibitors
- 2009-06-18: New biological therapy Ilaris® approved in US to treat children and adults with CAPS, a life-long auto-inflammatory disease
- 2009-06-01: GlaxoSmithKline: FDA Advisory Panel Makes Favorable Recommendation For ARZERRA (Ofatumumab)